Episode 2 of 3 in Dinner with the Docs – Southern California
What Are the First-Line Treatment Options for Multiple Myeloma?
What are the first-line treatment options for a newly diagnosed multiple myeloma patient? What questions should you ask your doctor to determine the best course of care for your needs? Finally, what are some of the side effects patients may face?
In this video excerpt from our recent “Dinner with the Docs” program on living with multiple myeloma, host and patient advocate Jack Aiello is joined by Dr. James Berenson, MD, Founder and Principal of the Berenson Cancer Center and Dr. Alberto Bessudo, MD, FACP, Medical Oncologist at the Compassionate Oncology Medical Group to discuss everything you need to know about first-line treatments.
Drugs Used for Myeloma are Helping Fight COVID-19
Several anti-inflammatory drugs used to treat multiple myeloma are showing promising results treating Covid-19. Read More
CAN DIET AND SUPPLEMENTS PREVENT SMOLDERING MYELOMA FROM PROGRESSING
Is there a proven diet that can keep smoldering myeloma from progressing? What about fasting and taking supplements? What do the experts recommend? Read More
DOES SMOLDERING MYELOMA TREATMENT NEED TO BE AGGRESSIVE?
Smoldering myeloma happens when changes in the blood are caught early in a blood test and is a precursor to multiple myeloma. What is it like living with smoldering myeloma and how aggressively should you be monitored and treated? Read More
LYMPHOMA & MYELOMA CONGRESS NYC OCTOBER 2019: PREDICTING PATIENT OUTCOMES WITH MM USING SERUM B-CELL MATURATION ANTIGEN:
New York—In a presentation at the 2019 Lymphoma & Myeloma congress, James R. Berenson, MD, Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research, West Hollywood, California, spoke about the use of serum B-cell maturation antigen (sBCMA) to predict outcomes in patients with multiple myeloma (MM). Read More